. operating service business in providing health care facilities for patients with end-stage chronic kidney disease who receive replacement therapy with dialysis kidneys (Dialysis Center). In , the KT Medical
customer group continuously. Include activities to promote and educate cleaners and disinfectants to target customers in order to realize the importance and improve the quality of goods and services as well
consistent with the business model of the customer group continuously. Include activities to promote and educate cleaners and disinfectants to target customers in order to realize the importance and improve
Hemodialysis Solution continuously. Management’s discussion and analysis for the year 2019 2 / 8 KT Medical Services Co., Ltd. provides health care facilities for patients with end-stage renal disease treated
year. Regarding Coronavirus Disease 2019 (COVID-19), the pace of growth in investment would be slow accordingly. When comparing the sale volume to the same period in Q1/2019, increased 12.2%. The company
companies are instructed to comply with the Guidelines for Prevention and Control of the Novel Coronavirus Disease 2019 (COVID-19) in Case of Holding Meetings, Seminars or Other Activities of Similar Nature
group continuously. Include activities to promote and educate cleaners and disinfectants to target customers in order to realize the importance and improve the quality of goods and services as well. At
uncertainty of US economic policy. However, the global economy has continued to improve. Thai economy is growing as slowly which the tourism and exports were driving force in the first half year. Income and
Revenue 6,726.6 7,034.7 (308.1) (4.4) Total Operating Expenses 6,042.3 6,352.9 (310.6) (4.9) Profit 541.6 527.1 14.5 2.8 In the first half year of 2022, the epidemic situation of the Coronavirus Disease
restoration, agroforestry and rural energy projects to improve food security for rural communities and increase farmers’ revenues. Link http://www.livelihoods.eu/lcf/ 5 Danone communities is a Venture Capital